ENSG00000105610


Homo sapiens

Features
Gene ID: ENSG00000105610
  
Biological name :KLF1
  
Synonyms : KLF1 / Kruppel like factor 1 / Q13351
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 19
Strand: -1
Band: p13.13
Gene start: 12884422
Gene end: 12887199
  
Corresponding Affymetrix probe sets: 210504_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000264834
NCBI entrez gene - 10661     See in Manteia.
OMIM - 600599
RefSeq - NM_006563
RefSeq - XM_011527642
RefSeq Peptide - NP_006554
swissprot - Q13351
Ensembl - ENSG00000105610
  
Related genetic diseases (OMIM): 111150 - Blood group--Lutheran inhibitor, 111150
  613566 - [Hereditary persistence of fetal hemoglobin], 613566
  613673 - Dyserythropoietic anemia, congenital, type IV, 613673

This gene has been taged as a transcription factor by TFT
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 klf2aENSDARG00000042667Danio rerio
 klf2bENSDARG00000040432Danio rerio
 ENSGALG00000010101Gallus gallus
 Klf1ENSMUSG00000054191Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
KLF2 / Q9Y5W3 / Kruppel like factor 2ENSG0000012752836
KLF4 / O43474 / Kruppel like factor 4ENSG0000013682636
KLF5 / Q13887 / Kruppel like factor 5ENSG0000010255430
KLF6 / Q99612 / Kruppel like factor 6ENSG0000006708228
KLF7 / O75840 / Kruppel like factor 7ENSG0000011826327
KLF15 / Q9UIH9 / Kruppel like factor 15ENSG0000016388427
KLF12 / Q9Y4X4 / Kruppel like factor 12ENSG0000011892227
KLF8 / O95600 / Kruppel like factor 8ENSG0000010234926
KLF3 / P57682 / Kruppel like factor 3ENSG0000010978724
KLF17 / Q5JT82 / Kruppel like factor 17ENSG0000017187223
KLF18 / Kruppel like factor 18ENSG0000028303922


Protein motifs (from Interpro)
Interpro ID Name
 IPR013083  Zinc finger, RING/FYVE/PHD-type
 IPR013087  Zinc finger C2H2-type
 IPR031784  Krueppel-like factor 1, transactivation domain 2
 IPR031786  Krueppel-like factor 1, transactivation domain 1
 IPR036236  Zinc finger C2H2 superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006351 transcription, DNA-templated IEA
 biological_processGO:0006355 regulation of transcription, DNA-templated IMP
 biological_processGO:0006357 regulation of transcription by RNA polymerase II IEA
 biological_processGO:0030218 erythrocyte differentiation IMP
 biological_processGO:0045893 positive regulation of transcription, DNA-templated IDA
 biological_processGO:0060135 maternal process involved in female pregnancy IEA
 biological_processGO:1901653 cellular response to peptide IEA
 cellular_componentGO:0000790 nuclear chromatin IDA
 cellular_componentGO:0005634 nucleus IEA
 cellular_componentGO:0005654 nucleoplasm IDA
 molecular_functionGO:0000981 RNA polymerase II transcription factor activity, sequence-specific DNA binding NAS
 molecular_functionGO:0000987 proximal promoter sequence-specific DNA binding IDA
 molecular_functionGO:0003676 nucleic acid binding IEA
 molecular_functionGO:0003677 DNA binding IEA
 molecular_functionGO:0003700 DNA-binding transcription factor activity TAS
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0044212 transcription regulatory region DNA binding IDA
 molecular_functionGO:0046872 metal ion binding IEA


Pathways (from Reactome)
Pathway description
No match


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000980 Pallor 
Show

 HP:0001639 Hypertrophic cardiomyopathy 
Show

 HP:0001744 Splenomegaly "An abnormal enlargement of the spleen." [HPO:curators]
Show

 HP:0001789 Hydrops fetalis 
Show

 HP:0001903 Anemia 
Show

 HP:0001923 Reticulocytosis 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002904 Hyperbilirubinemia 
Show

 HP:0003330 Abnormal bone laboratory examination 
Show

 HP:0003577 Onset at birth 
Show

 HP:0004322 Decreased body height "A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to "short stature" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms)." [HPO:curators]
Show

 HP:0010971 Absence of Lutheran antigen on erythrocytes "Absence of the Lutheran antigen (a type I integral membrane glycoprotein) from the sruface of red blood cells." [HPO:probinson]
Show

 HP:0010972 Anemia of inadequate production "A kind of `anemia` (HP:0001903) characterized by inadequate production of erythrocytes." [HPO:probinson]
Show

 HP:0011904 Persistence of hemoglobin F "Hemoglobin F (HbF) contains two globin alpha chains and two globin gamma chains. It is the main form of hemoglobin in the fetus during the last seven months of intrauterine development and in the half year of postnatal life. In adults it normally makes up less than one percent of all hemoglobiin. This term refers to an increase in HbF above this limit. In beta thalassemia major, it may represent over 90 percent of all hemoglobin, and in beta thalassemia minor it may make up between 0.5 to 4 percent." [HPO:probinson]
Show

 HP:0012132 Erythroid hyperplasia "Increased count of erythroid precursor cells, that is, `erythroid lineage cells` (CL:0000764) in the bone marrow." [DDD:akelly]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
No match






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr